However, candidates must generally meet specific medical criteria, typically including being obese with a BMI of 30 or higher or being overweight with a BMI of 27 or higher while also having one or more weight-related health conditions
Availability depends on regulatory status and research authorization in each region
Promoting Significant Weight Reduction: Through its combined effects on appetite, satiety, and metabolism, Semaglutide can lead to meaningful and sustained weight loss when used in conjunction with a balanced diet and regular exercise
Alkhouri N, Herring R, Kabler H, Kayali Z, Hassanein T, Kohli A, Huss RS, Zhu Y, Billin AN, Damgaard LH
This IV treatment offers a supportive approach to managing digestive health and fostering long-term wellness
GLP-1 medications can cause muscle mass loss due to their rapid weight loss effects, Schneider notes